Gender-Affirming Therapy and Bone Health
Image For Activity Cover
Availability
On-Demand
Expires on Dec 31, 2022
Cost
$0.00
Credit Offered
1 Participation Credit
  • Registration Requirements
  • Target Audience
  • Course Description
  • Learning Objectives
  • Faculty and Disclosures:
  • Recommended

This webinar is free to non-Endocrine Society members as a preview of the Endocrine Society’s educational offerings.  If this course expands your knowledge and you would like to gain access to all Special Interest Group (SIG) webinar content, the full course library in the Center for Learning, and many other member benefits, join Endocrine Society today!

The intended audience for this activity includes a wide range of health care providers; many may deem this presentation beneficial.

Join the Transgender Research and Medicine SIG for a webinar on the latest gender-affirming therapies and their relation to patient bone health.

 

  • Distinguish the effect of puberty blockers, estrogen and testosterone on bone turnover in transgender patients.
  • Outline the clinical approach to bone health for transgender people on gender-affirming hormone therapy.
  • Compare and contrast bone mass & bone remodeling in young adults to aging cis-women & men, and in transgender adults and adolescents on gender-affirming hormone therapy.

Vin Tangpricha, MD, PhD, Professor of Medicine, Emory University School of Medicine, Staff Physician, Atlanta VA Medical Center

No relevant commercial relationships. Grants: NIH and Cystic Fibrosis Foundation.

 

Radhika Narla, MD, Assistant Professor Medicine, Fellowship Program VA Site Coordinator, University of Washington

No relevant commercial relationships.

   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By